We, the Alliance for Longevity Initiatives (A4LI), call on ARPA-H Director Dr. Renee Wegrzyn to make a majority of program managers shift their focus towards longevity-focused biomedical research and geroscience.

As the population continues to age, the need for research and development in the field of longevity-focused research becomes increasingly urgent. With the current focus on the pandemic and other pressing health issues, it is easy to overlook the importance of this field. However, it is vital to remember that aging is the biggest risk factor for the development of chronic diseases such as cancer, diabetes, and heart disease. Furthermore, research on aging and longevity will not only benefit the elderly, but it will also have a positive impact on the overall health and well-being of the American population.

We urge Dr. Wegrzyn and the ARPA-H to invest in research on the underlying mechanisms of aging, the development of interventions that can delay or prevent age-related diseases, and the identification of potential therapies to extend healthy human lifespan. This will not only improve the quality of life for Americans but also reduce the burden on our healthcare systems, ultimately saving lives.

That is why now is the time to take action and make longevity-focused research and geroscience a priority. By signing this petition, we demonstrate our support for this important cause and urge ARPA-H to take action.